Marker Therapeutics (MRKR) Earnings Date, Estimates & Call Transcripts $1.17 -0.02 (-1.68%) Closing price 04/23/2025 03:59 PM EasternExtended Trading$1.18 +0.01 (+0.94%) As of 04/23/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marker Therapeutics Earnings Summary Upcoming Q1 Earnings DateMay. 21Before Market OpensEstimatedConsensus EPS (Mar. 31) -$0.28 Actual EPS (Mar. 31) -$0.42 Missed By -$0.14 Actual Revenue (Mar. 31) $1.22MMarker Therapeutics released Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.42, which missed analysts' consensus estimates of -$0.28 by $0.14. Quarterly revenue was reported to be $1.22 million, below analyst estimates of $5.25 million. With a trailing EPS of -$1.20, Marker Therapeutics' earnings are expected to decrease next year, from ($0.65) to ($2.19) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportMRKR Upcoming EarningsMarker Therapeutics' next earnings date is estimated for Wednesday, May 21, 2025, based on past reporting schedules. Get Marker Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Marker Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMRKR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRKR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Marker Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.66-$0.66-$0.66Q2 20251-$0.77-$0.77-$0.77Q3 20251-$1.14-$1.14-$1.14Q4 20251-$1.80-$1.80-$1.80FY 20254($4.37)($4.37)($4.37) Marker Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)--------3/31/2025Q4 2024-$0.28-$0.42 -$0.14-$0.42$5.25M$1.22M8/14/2024Q2 2024--$0.25 -$0.25-$0.25-$1.17M5/15/2024Q1 2024--$0.27 -$0.27-$0.27-$1.24M11/9/2023Q3 2023--$0.34 -$0.34-$0.34-$0.26M8/14/2023Q2 2023--$0.47 -$0.47-$1.23-$0.76M5/16/2023Q1 2023--$0.57 -$0.57-$0.57-$4.73M Marker Therapeutics Earnings - Frequently Asked Questions When is Marker Therapeutics's earnings date? Marker Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on MRKR's earnings history. Did Marker Therapeutics beat their earnings estimates last quarter? In the previous quarter, Marker Therapeutics (NASDAQ:MRKR) missed the analysts' consensus estimate of ($0.28) by $0.14 with a reported earnings per share (EPS) of ($0.42). Learn more on analysts' earnings estimate vs. MRKR's actual earnings. How much revenue does Marker Therapeutics generate each year? Marker Therapeutics (NASDAQ:MRKR) has a recorded annual revenue of $6.59 million. How much profit does Marker Therapeutics generate each year? Marker Therapeutics (NASDAQ:MRKR) has a recorded net income of -$8.24 million. MRKR has generated -$1.20 earnings per share over the last four quarters. What is Marker Therapeutics's EPS forecast for next year? Marker Therapeutics's earnings are expected to decrease from ($0.65) per share to ($2.19) per share in the next year. More Earnings Resources from MarketBeat Related Companies RPTX Earnings Results ONCY Earnings Results PEPG Earnings Results IMRX Earnings Results PDSB Earnings Results SKYE Earnings Results GANX Earnings Results ICCC Earnings Results CUE Earnings Results VNRX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InCan IBM’s Q1 Earnings Spark a Breakout for the Stock?Genuine Parts: Solid Earnings But Economic Uncertainties RemainBreaking Down Taiwan Semiconductor's Earnings and Future UpsideArcher Aviation Unveils NYC Network Ahead of Key Earnings Report This page (NASDAQ:MRKR) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
